R Squared LTD Maxcyte, Inc. Transaction History
R Squared LTD
- $181 Billion
- Q2 2025
A detailed history of R Squared LTD transactions in Maxcyte, Inc. stock. As of the latest transaction made, R Squared LTD holds 10,300 shares of MXCT stock, worth $14,213. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,300Holding current value
$14,213% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding MXCT
# of Institutions
120Shares Held
69MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY10MShares$13.8 Million1.17% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$11.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY7MShares$9.66 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$7.68 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$6.96 Million13.13% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $140M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...